Results 11 to 20 of about 78,583 (237)

Editöre Mektup - Red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention

Türk Kardiyoloji Derneği Arşivi, 2016
red cell distribution width and contrast-induced nephropathy in patients underwent primary percutaneous coronary intervention red cell distribution width and contrast-induced nephropathy in patients underwent primary percutaneous coronary intervention ...
Somsri Wiwanitkit, Viroj Wiwanitkit
doaj   +1 more source

Impact of the Total Ischemia Time on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Anatolian Journal of Cardiology, 2022
Background: No-reflow phenomenon after primary percutaneous coronary intervention is a common condition affecting the outcomes; therefore, studying its predictive factors is helpful in identifying patients at high risk.
Mohamed Khalfallah, Amany Allaithy, Dina Abdelsalam   +2 more
doaj   +1 more source

COMPARISON OF EFFECT OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION WITH STREPTOKINASE IN ACUTE ST ELEVATION MYOCARDIAL INFARCTION (STEMI) ON LEFT VENTRICULAR FUNCTION AFTER 3 MONTHS

Pakistan Armed Forces Medical Journal, 2020
Objective: To assess the left ventricular function three months after the primary percutaneous coronary intervention versus Streptokinase in ST elevation myocardial infarction. Study Design: Prospective comparative study.
Saleha Abbas, Abdul Hameed Siddiqui, Ammar Cheema, Ayesha Abbas, Sadaf Khan, Anum Fatima Janjua, Farhan Tuyyab   +6 more
doaj   +1 more source

Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction

Trials, 2010
Background In the setting of primary percutaneous coronary intervention, patients with a chronic total occlusion in a non-infarct related artery were recently identified as a high-risk subgroup.
Tuseth Vegard, Olivecrona Göran K, Strauss Bradley H, Bax Matthijs, Barbato Emanuele, Suttorp Maarten J, Koolen Jacques J, Verouden Niels J, Hoebers Loes P, Claessen Bimmer E, van der Schaaf René J, Glogar Dietmar, Råmunddal Truls, Tijssen Jan G, Piek Jan J, Henriques José PS   +15 more
doaj   +1 more source

A rare complication of primary percutaneous coronary intervention: Left atrial dissection and hematoma

Research in Cardiovascular Medicine, 2016
Introduction: Left atrial dissection and hematoma are a life threatening condition, which are rarely seen following percutaneous coronary interventions.
M Fikri Yapici, Nihat Ozer, Arda Sanli Okmen, Altug Sagir, Tarik Bugra Denizalti, Azmi Ozler   +5 more
doaj   +1 more source

Feasibility and Safety of Distal Radial Artery Access in Anatomical Snuffbox for Coronary Angiography and Coronary Intervention

Journal of Nepal Health Research Council, 2020
Background: There is limited data on feasibility and safety of coronary interventions performed using radial artery at anatomical snuffbox as vascular access point in South Asian region. Our study attempts to evaluate the feasibility and safety
Arun Maskey, Birat Krishna Timalsena, Sheikh Aslam, Rabindra Pandey, Madhu Roka, Shreya Bhandari, Himamshu Nepal   +6 more
doaj   +1 more source

Primary Percutaneous Coronary Interventions in Nonagenarians [PDF]

Clinical Cardiology, 2010
AbstractBackground:The optimal treatment of very elderly patients with ST elevation myocardial infarction (STEMI) is not yet defined. The aim of this study is to present the feasibility and safety of primary percutaneous coronary interventions (PCI) in nonagenarians.Methods:A retrospective analysis of all patients who underwent primary PCI due to STEMI
Michael, Koutouzis, Lars, Grip, Göran, Matejka, Per, Albertsson   +3 more
openaire   +2 more sources

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration

Trials, 2009
Background Administration of abciximab during primary percutaneous coronary intervention is an effective adjunctive therapy in the treatment of patients with ST-segment elevation myocardial infarction.
Gu Youlan L, Fokkema Marieke L, Kampinga Marthe A, de Smet Bart JGL, Tan Eng S, van den Heuvel Ad FM, Zijlstra Felix   +6 more
doaj   +1 more source

Successful percutaneous management of extensive iatrogenic aortocoronary dissection complicating primary percutaneous coronary intervention (PCI): A case report

IHJ Cardiovascular Case Reports, 2022
Iatrogenic aortocoronary dissection is a scarcely reported complication of cardiac catheterization, which can be fatal if not managed promptly. We present a case of extensive aortocoronary dissection extending into aortic arch in a patient undergoing ...
Navdeep Singh Sidhu, Himanshu Mahla
doaj   +1 more source

Drug-Coated Balloon in Primary Percutaneous Coronary Intervention

Journal of Interventional Cardiology, 2023
According to the latest coronary interventional guidelines, a drug-eluting stent is the recommended reperfusion therapy in primary percutaneous coronary intervention (pPCI). However, deficiencies and defects, such as in-stent restenosis (ISR), incomplete
Hui Zhao, Runran Miao, Fei Lin, Guoan Zhao   +3 more
doaj   +1 more source